Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer

Fig. 2

5-year overall survival analysis of each group divided according to venous invasion. The cumulative 5-year overall survival (OS) rate of the total 97 patients with Stage III gastric cancer was 42.6%. The patients with venous invasion exhibited a significantly poorer OS than patients with gastric cancer of other histological types (5-year OS, 33.7% vs. 50.4%, P = 0.027)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us